These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1461657)

  • 1. Alternative splicing in the human lck gene leads to the deletion of exon 1' and results in a new type II lck transcript.
    Rouer E; Benarous R
    Oncogene; 1992 Dec; 7(12):2535-8. PubMed ID: 1461657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of expression of five alternative transcripts of the lck gene in different hematopoietic malignancies: correlation of the level of lck messenger RNA I B with the immature phenotype of the malignancy.
    Rouer E; Dreyfus F; Melle J; Benarous R
    Cell Growth Differ; 1994 Jun; 5(6):659-66. PubMed ID: 8086341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent activation of the lck gene by promoter insertion and aberrant splicing in murine leukemia virus-induced rat lymphomas.
    Shin S; Steffen DL
    Oncogene; 1993 Jan; 8(1):141-9. PubMed ID: 8423992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alternatively spliced lck transcripts from the proximal promoter in colorectal cancer derived cell lines.
    Mayer K; Ballhausen WG
    Anticancer Res; 1996; 16(4A):1733-7. PubMed ID: 8712692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
    Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
    Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single base mutation in the 5' splice site of intron 7 of the lck gene is responsible for the deletion of exon 7 in lck mRNA of the JCaM1 cell line.
    Rouer E; Brule F; Benarous R
    Oncogene; 1999 Jul; 18(29):4262-8. PubMed ID: 10435639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of two classes of lck transcripts upon phorbol ester treatment of human leukemic T cells.
    Leung S; Miyamoto NG
    J Cell Physiol; 1991 Sep; 148(3):344-52. PubMed ID: 1918168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
    Adler HT; Sefton BM
    Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of an ETS-binding element for transcription of the human lck type I promoter.
    Leung S; McCracken S; Ghysdael J; Miyamoto NG
    Oncogene; 1993 Apr; 8(4):989-97. PubMed ID: 8455950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure function analysis of SH2D2A isoforms expressed in T cells reveals a crucial role for the proline rich region encoded by SH2D2A exon 7.
    Granum S; Sundvold-Gjerstad V; Dai KZ; Kolltveit KM; Hildebrand K; Huitfeldt HS; Lea T; Spurkland A
    BMC Immunol; 2006 Jul; 7():15. PubMed ID: 16839418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an alternatively spliced transcript of human interleukin-4 lacking the sequence encoded by exon 2.
    Sorg RV; Enczmann J; Sorg UR; Schneider EM; Wernet P
    Exp Hematol; 1993 Apr; 21(4):560-3. PubMed ID: 8462665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic organization and structure of the 5'-flanking region of the TEX101 gene: alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region.
    Tsukamoto H; Takizawa T; Takamori K; Ogawa H; Araki Y
    Mol Reprod Dev; 2007 Feb; 74(2):154-62. PubMed ID: 16941676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter.
    Nishio H; Takeshima Y; Narita N; Yanagawa H; Suzuki Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
    J Clin Invest; 1994 Sep; 94(3):1037-42. PubMed ID: 8083345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An additional exon of stress-inducible heat shock protein 70 gene (HSP70-1).
    Shimizu S; Nomura K; Ujihara M; Demura H
    Biochem Biophys Res Commun; 1999 Apr; 257(1):193-8. PubMed ID: 10092532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel interleukin-15 (IL-15) transcript isoform generated by alternative splicing in human small cell lung cancer cell lines.
    Meazza R; Verdiani S; Biassoni R; Coppolecchia M; Gaggero A; Orengo AM; Colombo MP; Azzarone B; Ferrini S
    Oncogene; 1996 May; 12(10):2187-92. PubMed ID: 8668345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing and nonsense-mediated mRNA decay in the regulation of a new adenomatous polyposis coli transcript.
    De Rosa M; Morelli G; Cesaro E; Duraturo F; Turano M; Rossi GB; Delrio P; Izzo P
    Gene; 2007 Jun; 395(1-2):8-14. PubMed ID: 17360132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
    Zhang DL; Ji L; Li YD
    Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four murine c-abl mRNAs arise by usage of two transcriptional promoters and alternative splicing.
    Bernards A; Paskind M; Baltimore D
    Oncogene; 1988 Apr; 2(4):297-304. PubMed ID: 3283651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.